22nd Century Group to Hold Conference Call to Provide Business Update For Investors
November 21 2014 - 12:41PM
Business Wire
22nd Century Group, Inc. (NYSE MKT:XXII) announced today that
Henry Sicignano III, President and Chief Operating Officer of 22nd
Century Group, together with Richard M. Sanders, an independent
Director of 22nd Century Group, will provide a business update for
investors on Tuesday, November 25th at 10:00 AM (EST).
The conference call is expected to reach hundreds of
participants from the investment sector and tobacco industry.
Chardan Capital Markets Senior Research Analyst, James McIlree,
will moderate the call. Interested parties are invited to
participate in the call by dialing: (888) 438-5525 and using
Conference ID 6119197.
The conference call will consist of a brief overview of recent
business highlights and a summary of the Company's plans for the
first half of 2015. Immediately thereafter, there will be a
question and answer segment open to all callers.
Henry Sicignano stated, “We believe that recent changes by 22nd
Century that place primary focus on near-term revenue opportunities
will be beneficial to the Company and to shareholder value.
Accordingly, we are pleased to be able to provide a business update
to increase awareness about our Company and to describe our
excellent business prospects.”
For additional information, please visit:
www.xxiicentury.com
22nd Century Group to Present at LD Micro Investor Conference
on December 3rd
Separately, 22nd Century announced today that the Company will
be a featured presenter at the LD Micro Investor Conference in Los
Angeles, California. Mr. Sicignano will make a presentation to
institutional investors and high net worth retail investors at this
invitational conference on Wednesday, December 3rd, 2014 at 9:30 AM
PST / 12:30 PM EST at the Luxe Sunset Boulevard Hotel in Los
Angeles.
"We are honored to have 22nd Century Group present at the
conference," stated Chris Lahiji, President of LD Micro.
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company whose proprietary
technology allows for the levels of nicotine and other nicotinic
alkaloids (e.g., nornicotine, anatabine and anabasine) in the
tobacco plant to be decreased or increased through genetic
engineering and plant breeding. The Company’s technology also
allows the levels of cannabinoids to be decreased or increased in
the cannabis plant. 22nd Century owns or is the exclusive licensee
of 129 issued patents in 78 countries plus an additional 51 pending
patent applications; 22nd Century also holds co-exclusive rights to
another 16 patent applications. Goodrich Tobacco is focused on
commercial tobacco products and potentially less harmful
cigarettes. Botanical Genetics is focused on novel cannabis plant
varieties and on cannabis-based products. Hercules Pharmaceuticals
is focused on X-22, a prescription smoking cessation aid in
development.
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of 22nd Century Group, Inc.,
its directors or its officers with respect to the contents of this
press release. The words “may,” “would,” “will,” “expect,”
“estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. We cannot guarantee future results,
levels of activity or performance. You should not place undue
reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should
be considered with any written or oral forward-looking statements
that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances, or to reflect the occurrence of unanticipated
events. You should carefully review and consider the various
disclosures made by us in our annual report on Form 10-K for the
fiscal year ended December 31, 2013, filed on January 30, 2014,
including the section entitled “Risk Factors,” and our other
reports filed with the U.S. Securities and Exchange Commission
which attempt to advise interested parties of the risks and factors
that may affect our business, financial condition, results of
operation and cash flows. If one or more of these risks or
uncertainties materialize, or if the underlying assumptions prove
incorrect, our actual results may vary materially from those
expected or projected.
Redington, Inc.Tom Redington, 203-222-7399
22nd Century (AMEX:XXII)
Historical Stock Chart
From Aug 2024 to Sep 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Sep 2023 to Sep 2024